ReferIndia News Bracing for a flood of semaglutide generics, Novo holds the price line

ReferIndia News

Mumbai’s Trusted Investment Experts

24+ years of financial planning, portfolio management & wealth growth.

Learn More
News Image

Bracing for a flood of semaglutide generics, Novo holds the price line

Published on: March 17, 2026, 7:33 p.m. | Source: Business Standard

Generic Semaglutide: Novo Nordisk says competition in semaglutide will be driven by science and quality, not pricing, as multiple generic versions prepare to enter India after patent expiry

Checkout more news
Ad Banner

✅ Secure, cloud-based clinic management software

Manage digital prescriptions, appointments, patient records, billing, files, and reports — everything your clinic needs in one powerful platform.

Know more
ReferIndia News contact